Shionogi Pharma Files Baktar Small-Sized Tablets to Improve Compliance in Children

August 31, 2020
Shionogi Pharma, a manufacturing subsidiary of Shionogi, said on August 28 that it has filed a small-sized version of the synthetic antimicrobial agent Baktar Combination Tablets (sulfamethoxazole + trimethoprim) in Japan, seeking to improve compliance in pediatric patients. Baktar was...read more